Foamix Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Foamix Pharmaceuticals's estimated annual revenue is currently $7.8M per year.
- Foamix Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Foamix Pharmaceuticals has 39 Employees.
- Foamix Pharmaceuticals grew their employee count by -2% last year.
Foamix Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | sVP Clinical Development | Reveal Email/Phone |
3 | General Counsel & SVP, Legal Affair | Reveal Email/Phone |
4 | SVP, Global Human Resources | Reveal Email/Phone |
5 | SVP | Reveal Email/Phone |
6 | Director | Reveal Email/Phone |
Foamix Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $16.7M | 83 | -34% | $237M | N/A |
#2 | $7.8M | 39 | -2% | N/A | N/A |
#3 | $33.8M | 168 | 24% | N/A | N/A |
#4 | $11.3M | 56 | 19% | N/A | N/A |
#5 | $10.3M | 51 | -12% | N/A | N/A |
#6 | $11.7M | 58 | 1060% | N/A | N/A |
#7 | $9.6M | 48 | 41% | N/A | N/A |
What Is Foamix Pharmaceuticals?
Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology. Our clinical stage product candidates include FMX101, our novel minocycline foam for the treatment of moderate-to-severe acne, FMX103 for the treatment of moderate-to-severe rosacea.
keywords:N/AN/A
Total Funding
39
Number of Employees
$7.8M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Foamix Pharmaceuticals News
... Biotechnology Co., Ltd, Foamix Pharmaceuticals Ltd, Maruho Co.,Ltd., Sinovac Biotech Ltd, Hepion Pharmaceuticals, CELGENE CORPORATION.
Foamix Pharmaceuticals, Galderma, Sol-Gel Technologies, Bayer, Valeant Pharmaceuticals International, Nestl S.A., Bausch Health Companies Inc., Allergan.
Company profiling of Foamix Pharmaceuticals Ltd., Bausch Health Companies Inc. (Formerly Valeant Pharmaceuticals), Nestle (Galderma S.A.)...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.8M | 45 | 2% | N/A |
#2 | $5.2M | 46 | -12% | N/A |
#3 | $6.6M | 46 | 31% | N/A |
#4 | $10.3M | 51 | -12% | N/A |
#5 | N/A | 56 | -8% | N/A |